In conclusion, by its specific targeting of tumor cells, its solubility and its impact on cancer cell proliferation in vitro and in vivo, the [DLys6]-LHRH-curcumin hybrid appears attractive for further investigations and opens the way for the development of other GnRH analog-based nutraceutic hybrids [120]. Here, GNRH1 is linked to cancer.